169 related articles for article (PubMed ID: 16624548)
1. Breast cancer stem cells: an overview.
Ponti D; Zaffaroni N; Capelli C; Daidone MG
Eur J Cancer; 2006 Jun; 42(9):1219-24. PubMed ID: 16624548
[TBL] [Abstract][Full Text] [Related]
2. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
3. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
4. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
5. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
Pandit TS; Kennette W; Mackenzie L; Zhang G; Al-Katib W; Andrews J; Vantyghem SA; Ormond DG; Allan AL; Rodenhiser DI; Chambers AF; Tuck AB
Int J Oncol; 2009 Aug; 35(2):297-308. PubMed ID: 19578743
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
Theodoropoulos PA; Polioudaki H; Agelaki S; Kallergi G; Saridaki Z; Mavroudis D; Georgoulias V
Cancer Lett; 2010 Feb; 288(1):99-106. PubMed ID: 19619935
[TBL] [Abstract][Full Text] [Related]
9. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
[TBL] [Abstract][Full Text] [Related]
10. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
Fillmore C; Kuperwasser C
Breast Cancer Res; 2007; 9(3):303. PubMed ID: 17540049
[TBL] [Abstract][Full Text] [Related]
11. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
12. Stem cells and breast cancer.
Cariati M; Purushotham AD
Histopathology; 2008 Jan; 52(1):99-107. PubMed ID: 18171421
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells in breast cancer and metastasis.
Lawson JC; Blatch GL; Edkins AL
Breast Cancer Res Treat; 2009 Nov; 118(2):241-54. PubMed ID: 19731012
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer stem cells.
Kai K; Arima Y; Kamiya T; Saya H
Breast Cancer; 2010 Apr; 17(2):80-5. PubMed ID: 19806428
[TBL] [Abstract][Full Text] [Related]
15. Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action.
Marsden CG; Wright MJ; Pochampally R; Rowan BG
Methods Mol Biol; 2009; 590():363-75. PubMed ID: 19763516
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
Bauerschmitz GJ; Ranki T; Kangasniemi L; Ribacka C; Eriksson M; Porten M; Herrmann I; Ristimäki A; Virkkunen P; Tarkkanen M; Hakkarainen T; Kanerva A; Rein D; Pesonen S; Hemminki A
Cancer Res; 2008 Jul; 68(14):5533-9. PubMed ID: 18632604
[TBL] [Abstract][Full Text] [Related]
17. Recent translational research: stem cells as the roots of breast cancer.
Chang CC
Breast Cancer Res; 2006; 8(1):103. PubMed ID: 16524453
[TBL] [Abstract][Full Text] [Related]
18. Suspension culture combined with anticancer regimens for screening breast cancer stem cells.
Li HZ; Yi TB; Wu ZY
Med Hypotheses; 2007; 68(5):988-90. PubMed ID: 17125933
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the link between stem cells and breast cancer.
Cariati M
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1313-22. PubMed ID: 18699767
[TBL] [Abstract][Full Text] [Related]
20. [Analysis on clone in vitro and tumorigenic capacity in vivo of different subsets cells from the MCF-7 human breast cancer cell line].
Li Z; Liu CP; He YL; Tian Y; Huang T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):547-9. PubMed ID: 18798490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
